Office of Research Compliance News

Research Integrity Summit at Ohio State takes place September 23

Posted: June 19, 2018

Seeking Solutions in Research Integrity: A View from All Perspectives

The free, one-day national conference will bring together multiple stakeholders – researchers, institutions, publishers, funders, scientific societies, the press, and federal agencies – to discuss concerns in research integrity from different perspectives and to reflect on current efforts being taken to address these concerns. A broad collaboration between multiple partners in the research community will lay the foundation to detail next steps in fostering changes to enhance integrity in research.

Sunday, September 23, 2018
9 a.m. – 6 p.m.
The Blackwell Inn and Conference Center
The Ohio State University

Questions to be addressed:

  • How can institutions use the NASEM Report on Fostering Integrity in Research to effect positive change?
  • What can institutions do to create a more effective environment for scientists to perform research reflecting the highest standards of research integrity?
  • How can senior research leaders help their universities manage complex research misconduct matters:
  • What are current and developing guidance/policies from institutions and journals to tackle emerging research integrity issues?
  • What are the editorial challenges in managing falsification, fabrication and plagiarism?
  • How can research misconduct proceedings be handled to adapt to the current complexity of cases and adhere to confidentiality requirements and demands for transparency?
  • Next steps: Where do we go from here?

Visit the Research Integrity Summit website to view the agenda, list of speakers and travel information.

Category : General

Revised Export Control Policy Goes into effect April 15, 2018

Posted: April 13, 2018

Starting April 15, 2018, the revised Export Control policy will go into effect.  The revised policy applies to all university faculty, staff, students, visiting scholars, visitors, and all others retained or working at the university. Updates to the policy include revisions to descriptions of exports and sanctioned transactions to conform to recently revised federal regulations and existing export practice and expands the Procedure section to reflect current operating procedures.  All personnel are encouraged to become familiar with the revised policy, especially those working in defense-related research; engineering; physical and computer sciences; biological sciences with controlled organisms or toxins; medical research using high-end technology; and those conducting research or academic collaborations with colleagues in sanctioned countries.

Please see the Export Control webpage for more details.

Category : Export Control / General

2018 COI Disclosure is available on April 16 – April 20, 2018

Posted: April 4, 2018

2018 COI Disclosure is available on April 16 – April 20, 2018

NOTE:  Staff members, Administrators, Postdoctoral Researchers, and Students who are required to complete the 2018 eCOI form should be notified by email during the week of April 16 – 20.

The Ohio State University requires certain faculty members, staff members, postdoctoral researchers, and students to complete an annual financial disclosure to comply with federal conflict of interest (COI) regulations, accreditation requirements, and OSU faculty and staff COI policies. This year, the new disclosure period begins April 16, 2018 with a required one-year look back period for 2018 going back to April 16, 2017. COI disclosures should be completed by May 16, 2018 by going to

All individuals required to complete a COI disclosure will receive an email, advising them that the new disclosure period has opened, and that their 2018 disclosure should be completed. Instructions on how to complete the disclosure, along with information regarding what needs to be disclosed and how the disclosure is reviewed and approved, will be provided in the email and upon logging into the e-COI system at

If a 2017 disclosure form is on file, it will no longer be editable after April 16, 2018. Please note that the 2017 form will not expire until June 30, 2018. This provides individuals adequate time to complete the 2018 disclosure prior to expiration of the current disclosures. Reminder emails will be sent in May and June to all individuals who are required to, but have not yet completed, the 2018 COI disclosure.

If you have any questions about the research-related COI policy, please see:, or the FAQs at:

The Office of Research Compliance can be reached at 614-292-4284, or

Category : General

Garfinkel joins ORC as assistant vice president for research compliance

Posted: February 5, 2018

Susan Garfinkel

Susan Garfinkel

The Office of Research welcomes Dr. Susan Garfinkel. She joined the Office of Research Compliance as assistant vice president for research compliance in December 2017. Dr. Garfinkel will be responsible for developing, implementing and leading programs and policies to ensure the university is compliant with federal, state and private sponsor requirements as well as university policies to support and promote ethical research practices.

She will serve as the senior coordinator concerning research misconduct, providing oversight and advice to the university’s research integrity officers. Dr. Garfinkel will provide updates to university officials on the progress of any inquiry or investigation and make recommendations for university actions. Working in conjunction with the associate vice president for research compliance, she will coordinate institution-wide research compliance policies and procedures and work with faculty and administrative units to ensure that the university is compliant with federal and state regulations regarding export controls, conflict of interest, research misconduct, international research and research data security. She will also work with faculty, staff, students and administrative units to build awareness and develop strategies for effective ways to minimize and manage compliance risks.

Dr. Garfinkel brings a wealth of experience to this position. From 2013 to present, she served as the director of the Division of Investigative Oversight (DIO) at the U.S. Department of Health and Human Services Office of Research Integrity in Rockville, Maryland. In that position she supervised DIO scientist-investigators and support staff on matters related to case management and investigative strategy for all basic science and clinical research misconduct cases, from preliminary assessment of allegations through case resolution, in all fields of biomedical research. Prior to that, she served as a scientist-investigator for the DIO and director of research grants for the American Health Assistance Foundation.

Dr. Garfinkel received her BA in biology from SUNY at Binghamton and her PhD in genetics from George Washington University.

She is located in the Research Administration building at 1960 Kenny Road, room 204. She can be contacted at or 614-292-7150.

Category : General